1. Home
  2. RGCO vs RNAC Comparison

RGCO vs RNAC Comparison

Compare RGCO & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

N/A

Current Price

$22.23

Market Cap

232.9M

Sector

Utilities

ML Signal

N/A

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

N/A

Current Price

$7.32

Market Cap

204.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGCO
RNAC
Founded
1912
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
232.9M
204.6M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RGCO
RNAC
Price
$22.23
$7.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$38.40
AVG Volume (30 Days)
9.6K
110.5K
Earning Date
11-19-2025
11-06-2025
Dividend Yield
3.77%
N/A
EPS Growth
11.26
N/A
EPS
1.29
N/A
Revenue
$95,334,212.00
$1,091,000.00
Revenue This Year
$9.00
N/A
Revenue Next Year
$8.30
N/A
P/E Ratio
$17.10
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.06
$5.98
52 Week High
$23.82
$26.50

Technical Indicators

Market Signals
Indicator
RGCO
RNAC
Relative Strength Index (RSI) 58.49 38.43
Support Level $21.98 $7.23
Resistance Level $22.83 $7.73
Average True Range (ATR) 0.64 0.42
MACD 0.13 0.07
Stochastic Oscillator 75.90 12.73

Price Performance

Historical Comparison
RGCO
RNAC

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: